Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Galirayo who wrote (858)	2/23/2005 1:48:22 PM
From: Jibacoa	Respond to of 3722

Ray, If the plaintiffs win, it will affect the stem cell companies on a negative way since there will be less money available for grants.<g> The California Institute for Regenerative Medicine and similar ones founded in other estates was a way of bypassing some of the restrictions on SC's research from president Bush's directives. The companies that use ASCs will be less affected than those using ESCs. The groups that filed the lawsuits are trying to invalidate what California voters approved in November on Proposition 71 by a 59% margin. I have no idea how the courts will decide, but whenever the attorneys get involved, the field gets muddled or muddy.<g> As I mentioned on my note on MUCL and ASTM they have been benefiting by the fact that ASCs are not affected by the recent setbacks on ESCs.<g> RAGL Bernard